Skip to main content
. 2019 Jan 25;8(2):88. doi: 10.3390/cells8020088

Table 2.

Gene therapy tests and strategy used for HGPS treatment on tissue culture and mouse models.

Strategy Reference Name and Target Sequence 5′->3′ Target Transcript
Silencing of transcript variant 7, binds specifically to transcript coding for progerin [144] shRNA3
GGCTCAGGAGCCCAGAGCCCC
Variant 7
[145]
[146]
Blocking the activated cryptic splice site in exon 11, binds directly to the sequence of cryptic splice site [104] Ex11
CTCAGGAGCCCAGGTGGGTGGACCC
Mutated pre-mRNA
[117]
[124]
[125]
[132]
Blocking the activated cryptic splice site in exon 11, binds upstream of this site [124] ASO 365
CTGTGCGGGACCTGCGGGCA
Mutated pre-mRNA
Binding to exon 10 splice site and shift splicing towards lamin C [104] Ex10
CCATCACCACCACGTGAGTGGTAGC
Pre-mRNA, mutated pre-mRNA
[117]
[132]